Výsledky vyhledávání - "A. K. Blystad"

Multimodal treatment with ALL-like chemotherapy, Auto-SCT and radiotherapy for lymphoblastic lymphoma

Autor: Stein Kvaløy, Arne Kolstad, A. K. Blystad, Grete F. Lauritzsen, Alexander Fosså, Harald Holte, Hanne Skjerven Bersvendsen, E. Aurlien

Publikováno v: Acta Oncologica. 53:680-687

Recommended treatment for lymphoblastic lymphomas, a highly aggressive, relatively rare lymphoma entity predominantly seen in teenagers and young adults, includes acute lymphoblastic leukemia (ALL)-like induction chemotherapy. Whether these patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d9c1e792901e34928a9728e282bc2fe
https://doi.org/10.3109/0284186x.2013.855816

Zobrazit plný text záznamu

Høydosebehandling med autolog stamcellestøtte ved lymfom i Norge 1987 – 2008

Autor: Jon Håvard Loge, Stein Kvaløy, Arne Kolstad, A. K. Blystad, Bjørn Østenstad, Cecilie E. Kiserud, Alexander Fosså, Knut B. Smeland, Martin Maisenhölder, Unn-Merete Fagerli, Øystein Fluge, Jens Hammerstrøm, Harald Holte, Grete F. Lauritzsen

Publikováno v: Tidsskrift for Den norske legeforening. 133:1704-1709

Background High-dose therapy with autologous stem cell support (HDT) has been a treatment option for lymphomas in Norway for 25 years. The purpose of the article was to describe the use of the therapy for lymphomas for the country as a whole and by h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2130aab6ac8756745bafd0b679b84f82
https://doi.org/10.4045/tidsskr.13.0243

Zobrazit plný text záznamu

Two escalated followed by six standard BEACOPP in advanced-stage high-risk classical Hodgkin lymphoma: high cure rates but increased risk of aseptic osteonecrosis

Autor: E. Aurlien, Knut Håkon Hole, Arne Kolstad, A. K. Blystad, Harald Holte, Idun Fiskvik, Ida Münster Ikonomou, Alexander Fosså, Grete F. Lauritzsen

Publikováno v: Annals of Oncology. 23:1254-1259

Background: From 1999, Norwegian guidelines recommend two escalated (esc) BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisolone) followed by six standard (s) BEACOPP for patients with advanced-stage cla

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cbe41416bea18ef605734da846780bc
https://doi.org/10.1093/annonc/mdr385

Zobrazit plný text záznamu

Side population cells in highly enriched CD34-positive cells from peripheral blood progenitor cells identify an immature subtype of hematopoietic progenitor cells but do not predict time to engraftment in patients treated with high-dose therapy

Autor: Marianne Dyrhaug, Dag Josefsen, Gunnar Kvalheim, Trond Stokke, Erlend B. Smeland, A. K. Blystad, Lise Forfang

Publikováno v: European Journal of Haematology. 87:494-502

Objective: A Hoechst 33342 dye efflux assay can be used to define a population of immature hematopoietic progenitor cells (HPC) that are called side population (SP) cells. Previously, SP cells examined from bone marrow (BM) and peripheral blood proge

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c26222529ace5908b1455cc1371fd73f
https://doi.org/10.1111/j.1600-0609.2011.01681.x

Zobrazit plný text záznamu

Treatment of Burkitt's/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens

Autor: A. K. Blystad, Stein Kvaløy, Jan Delabie, Grete F. Lauritzsen, Jens Hammerstrøm, Sigbjørn Smeland, Ida Münster Ikonomou, Harald Holte, Gunnar Kvalheim

Publikováno v: Annals of Oncology. 15:1072-1078

Background: Burkitt’s/Burkitt-like lymphoma (BL/BLL) are highly aggressive lymphomas mainly affecting children and young adults. We report the results in adolescent and adult patients with the use of three successive regimens. Patients and methods:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a79544bbc344bb736dbb92d333497f4
https://doi.org/10.1093/annonc/mdh262

Zobrazit plný text záznamu

High-dose therapy in patients with Hodgkin's disease: the use of selected CD34+ cells is as safe as unmanipulated peripheral blood progenitor cells

Autor: Erlend B. Smeland, Stein Kvaløy, Jan Delabie, Gunnar Kvalheim, A. K. Blystad, Harald Holte

Publikováno v: Bone Marrow Transplantation

Register data suggest that patients with Hodgkin's disease (HD) given high-dose therapy (HDT) with peripheral blood progenitor cells (PBPC) have a less favourable prognosis as compared to those given bone marrow as stem cell support. Since this can b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31f155b123b76cf793493d152755c805
https://doi.org/10.1038/sj.bmt.1703244

Zobrazit plný text záznamu

High-Dose Therapy and Autologous Stem-Cell Support for Chemosensitive Transformed Low-Grade Follicular Non-Hodgkin’s Lymphoma: A Case-Matched Study From the European Bone Marrow Transplant Registry

Autor: Catherine D. Williams, C. N. Harrison, A. K. Blystad, G. Taghipour, Andrew J. Norton, A. H. Goldstone, B. Coiffier, N. Schmitz, T. A. Lister

Publikováno v: Journal of Clinical Oncology. 19:727-735

PURPOSE: To assess the outcome of high-dose therapy with autologous stem-cell support in patients with histologic transformation of low-grade follicular non-Hodgkin’s lymphoma (NHL) and identify significant prognostic factors, as well as to compare

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57efb71c68f39f040bca88cab06adf79
https://doi.org/10.1200/jco.2001.19.3.727

Zobrazit plný text záznamu

Retinoic acid induces apoptosis of human CD34+ hematopoietic progenitor cells

Autor: A. K. Blystad, Jon Lømo, Erlend B. Smeland, Dag Josefsen, Heidi Kiil Blomhoff

Publikováno v: Experimental Hematology. 27:642-653

Retinoids are bifunctional regulators of growth and differentiation of hematopoietic cells. In this study we explored the effects of retinoic acid (RA) on apoptosis of human CD34 + hematopoietic progenitor cells isolated from normal bone marrow. RA (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e4a9a0c09626f800b84d64241b778f72
https://doi.org/10.1016/s0301-472x(98)00073-3

Zobrazit plný text záznamu

High-dose therapy and autologous stem cell rescue for patients with Hodgkin’s disease in first relapse after chemotherapy: results from the EBMT

Autor: John W. Sweetenham, A. K. Blystad, G Taghipour, A Fassas, Dolores Caballero, D. W. Milligan, Ah Goldstone

Publikováno v: Bone Marrow Transplantation. 20:745-752

The purpose of this study was to investigate the results of high-dose therapy and autologous stem cell transplantation in adult patients with Hodgkin's disease in first relapse after chemotherapy, to determine the overall and progression-free surviva

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aa99d866343b515165fdf4c0487e500b
https://doi.org/10.1038/sj.bmt.1700963

Zobrazit plný text záznamu

Bone-marrow MR imaging before and after autologous marrow transplantation in lymphoma patients without known bone-marrow involvement

Autor: Hans H. Lien, A. K. Blystad, Harald Holte, Ruth Langholm, Stein Kvaløy, V. Blomlie

Publikováno v: Acta Radiologica. 38:896-902

Purpose: To study lumbar bone marrow by means of MR imaging before and after bone-marrow transplantation in lymphoma patients. Particular emphasis was paid to heterogeneity and to focal manifestations, i.e. appearances that could simulate tumor. Mate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8558e934d1719693fbc84ee4c99e26f1
https://doi.org/10.3109/02841859709172432

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání